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ABSTRACT
Introduction We aimed to investigate whether 
the proportion of undiagnosed diabetes varies by 
socioeconomic status and healthcare consumption, in a 
Norwegian population screened with glycated hemoglobin 
(HbA1c).
Research design and methods In this cohort study, we 
studied age- standardized diabetes prevalence using data 
from men and women aged 40–89 years participating in 
four surveys of the Tromsø Study with available data on 
HbA1c and self- reported diabetes: 1994–1995 (n=6720), 
2001 (n=5831), 2007–2008 (n=11 987), and 2015–2016 
(n=20 170). We defined undiagnosed diabetes as HbA1c 
≥6.5% (48 mmol/mol) and no self- reported diabetes. We 
studied the association of education, income and contact 
with a general practitioner on undiagnosed diabetes 
and estimated adjusted prevalence ratio (aPR) from 
multivariable adjusted (age, sex, body mass index) log- 
binomial regression.
Results Higher education was associated with lower 
prevalence of diagnosed and undiagnosed diabetes. 
Those with secondary and tertiary education had lower 
prevalence of undiagnosed diabetes (aPR for tertiary vs 
primary: 0.54, 95% CI: 0.44 to 0.66). Undiagnosed as a 
proportion of all diabetes was also significantly lower in 
those with tertiary education (aPR:0.78, 95% CI: 0.65 to 
0.93). Household income was also negatively associated 
with prevalence of undiagnosed diabetes. Across the 
surveys, approximately 80% of those with undiagnosed 
diabetes had been in contact with a general practitioner 
the last year, similar to those without diabetes.
Conclusions Undiagnosed diabetes was lower among 
participants with higher education. The hypothesis that 
those with undiagnosed diabetes had been less in contact 
with a general practitioner was not supported.
INTRODUCTION
Diabetes is a chronic metabolic condition 
characterized by high blood glucose levels. 
Type 2 diabetes may especially be unrecog-
nized for several years, and it has been esti-
mated that 25%–50% of all diabetes cases are 
undiagnosed.1 2 Monitoring the proportion 
of undiagnosed diabetes is critical to estimate 
the total diabetes burden and to evaluate 
public health efforts to prevent and diagnose 
diabetes. Screening with oral glucose toler-
ance tests (OGTTs), fasting plasma glucose 
(FPG) or glycated hemoglobin (HbA1c) may 
identify slightly different subsets of individuals 
with diabetes, and result in different diabetes 
prevalence estimates. Yet, at present, HbA1c 
has become the method of choice.3 4 Both the 
American Diabetes Association from 2009, 
and the WHO from 2011, have recommended 
HbA1c as the primary diagnostic test.
5 6 In 
Norway, HbA1c has been the preferred diag-
nostic method from September 2012.7 As 
HbA1c can be used in a non- fasting state, 
reflects the average blood glucose in the last 
8–12 weeks, and shows limited pre- analytical 
variation and low day- to- day variation, HbA1c 
is well suited for diabetes screening.6
There is limited information about time 
trends in undiagnosed diabetes from repeated 
population- based screening studies.8–12 Both 
Significance of this study
What is already known about this subject?
 ► Low socioeconomic status is associated with higher 
prevalence of undiagnosed diabetes.
What are the new findings?
 ► Lower education was associated with higher preva-
lence of undiagnosed diabetes.
 ► Lower income was also associated with undiag-
nosed diabetes even after adjustment for education.
 ► Nearly 80% of those with undiagnosed diabetes had 
been in contact with a general practitioner the last 
year.
How might these results change the focus of 
research or clinical practice?
 ► Those with low education had higher prevalence 
and higher proportion of undiagnosed diabetes sug-
gesting that efforts should be directed not only at 
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prevalence and incidence of type 2 diabetes are well 
known to be substantially higher in people with lower 
indicators of socioeconomic status such as education.13–16 
Fewer studies have investigated undiagnosed diabetes in 
association with socioeconomic status, but there is reason 
to believe that the prevalence of undiagnosed diabetes 
also varies in a similar way with socioeconomic status.1 17–19 
However, if both undiagnosed and diagnosed diabetes 
are more common in those with low education, it is not 
obvious whether undiagnosed diabetes as a proportion of 
all diabetes is higher in those with lower education.
An understudied question is to what degree people 
with undiagnosed diabetes have been seeing a doctor but 
were nevertheless not tested for diabetes, or they have 
simply not seen a doctor recently. Such information is 
important for targeting campaigns to reduce the occur-
rence of undiagnosed diabetes.
Since 1994, around 47 000 HbA1c samples have been 
collected in the population- based Tromsø Study.20 21 We 
aimed to investigate whether the proportion of undiag-
nosed diabetes varies by educational level and income, 
and to what degree people with undiagnosed diabetes 
have been in contact with a general practitioner (GP) in 
the 12 months prior to the health examination.
MATERIAL AND METHODS
Participants
The Tromsø Study is a large population- based prospec-
tive study among inhabitants of the Tromsø municipality, 
North Norway, currently with a population of 77 000. The 
study was initiated in 1974, and seven surveys (Tromsø 
1–7) have been performed to date. We used data from 
men and women aged 40–89 years participating in Tromsø 
4 (1994–1995), Tromsø 5 (2001), Tromsø 6 (2007–2008) 
and Tromsø 7 (2015–2016),20–22 who answered the 
question on self- reported diabetes and had at least one 
HbA1c measurement (see flow chart in online supple-
mental figure 1 and online supplemental methods). By 
design, the Tromsø 5 and Tromsø 6 surveys included 
different participant groups. In Tromsø 5, the largest 
group comprised individuals who had participated in 
the previous Tromsø 4 survey as well as a random sample 
consisted of people in the following age groups: 30, 40, 
45, 60 or 75 years. In Tromsø 6, men and women who 
previously had participated in Tromsø 4, a 10% random 
sample aged 30–39 years, all individuals aged 40–42 and 
60–87 years and a 40% random sample aged 43–59 years 
were invited.
Data collection
Trained personnel collected blood samples and data on 
physiological measurements. Laboratory analyses were 
performed at the University Hospital of North Norway, 
except for HbA1c in Tromsø 4 performed at the Labora-
tory for Metabolic Research at the University of Tromsø 
and HbA1c in Tromsø 5 performed at the study site labo-
ratory in accordance with the hospital gold standard. 
HbA1c was analyzed by immunoturbidimetry with Cobras 
Mira Plus (Unimate 5 HbA1c, F Hoffmann‐La Roche, 
Basel, Switzerland) (Tromsø 4),23 DCA 2000 (Bayer Diag-
nostics, Tarrytown, New York, USA) (Tromsø 5), and by 
high- performance liquid chromatography with Variant 
II (Bio- Rad Laboratories, Hercules, California, USA) 
(Tromsø 6)21 and Tosoh G8 (Tosoh Bioscience, San Fran-
cisco, USA) (Tromsø 7).
Data from questionnaire and examination
Information on education, income and GP visits was 
retrieved from questionnaires (online supplemental 
methods). Attained education level was stratified into 
three categories: (1) primary and lower secondary, (2) 
higher secondary (high school or vocational school) 
and (3) college and university, referred in the paper as 
primary, secondary and tertiary education. Total house-
hold income (in the last two surveys only) was divided 
in three categories, based on percentiles (<33, 33–66 
and over 66). Visit to a GP the previous 12 months was 
a yes/no question. Height and weight were measured at 
examination. Body mass index (BMI) was calculated as 
weight in kilograms divided by the square of height in 
meters (kg/m2). BMI was stratified into normal (<25 kg/
m2), overweight (25–29 kg/m2), obesity class I and II 
(30–39 kg/m2) and obesity class III (≥40 kg/m2).
Diabetes definition
Known diabetes was defined by the question ‘Do you 
have diabetes?’ retrieved from questionnaires (details 
described in the online supplemental methods). Undi-
agnosed diabetes or screening- detected diabetes was 
defined as HbA1c ≥6.5% (≥48 mmol/mol), and no self- 
reported diabetes.
Sensitivity analysis
In Tromsø 7, self- reported diabetes also included the 
answer category ‘Previously’. We assessed the influence 
of this on our results by rerunning analyses, including 
participants reporting previous diabetes in the ‘known 
diabetes’ category.
Statistical analysis
We estimated the crude and standardized prevalence of 
known and undiagnosed diabetes in the four surveys, 
stratified by educational level and other covariates. The 
various surveys’ data collections included different age 
groups. Therefore, the prevalence estimates were age 
standardized to the age distribution in the most recent 
survey using 5- year age groups. To assess potential influ-
ence of adjusting for covariates, we estimated adjusted 
prevalence ratio (aPR) and 95% CIs with log- binomial 
regression models and with undiagnosed diabetes as the 
outcome. The number of individuals with missing data on 
covariates was generally low and is specified in the foot-
notes of tables 1 and 2. Missing data were not imputed. 
In pooled analyses across multiple surveys, we accounted 
for repeated observations for individuals participating in 
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In addition, we accounted for time trends in education 
and diabetes prevalence by adjusting for age and period 
of survey. We assessed the relationship between HbA1c 
levels in the undiagnosed diabetes group and age, sex, 
BMI, educational level and household income. We esti-
mated the proportion of participants visiting a GP among 
those without diabetes and those with undiagnosed 
diabetes. Stata software was used for data management 
and statistical analysis (StataCorp, 2019; Stata Statistical 
Software: V.16; College Station, Texas, USA).
RESULTS
Analyses included 44 678 HbA1c measurements from 
27 576 participants (11 619 participated in two or more 
surveys). The age distribution varied by survey, and 
the proportion of participants with obesity and tertiary 
education was higher in the later surveys (table 1).
Diabetes prevalence was slightly higher among 
men than women throughout all surveys, and age was 
positively associated with the prevalence of both known 
and undiagnosed diabetes (online supplemental figure 
2). Undiagnosed diabetes as a proportion of all diabetes 
also tended to increase with age, from around 20% in 
those aged 40–49 years old to around 30% in those aged 
80–89 years old (online supplemental figure 3). Higher 
BMI was strongly associated with higher prevalence 
of both diagnosed and undiagnosed diabetes (online 
supplemental figure 4). Undiagnosed diabetes as a 
proportion of all cases tended to increase with increasing 
BMI, with some variation between surveys that may be 
due to small number of observations in some strata. 
Online supplemental table 1 presents the mean HbA1c 
stratified by survey, age and other characteristics in those 
participants without diagnosed diabetes and in those 
with undiagnosed diabetes.
Undiagnosed diabetes by education and income
Undiagnosed diabetes, both prevalence and as a propor-
tion of all diabetes, was more common in the group with 
Table 2 Associations between education and prevalence of undiagnosed diabetes, the Tromsø Study 1994–2016
Undiagnosed diabetes as % of people without 
known diabetes Undiagnosed as % of all diabetes
Primary and 
secondary




High school or 
vocational University
Tromsø 4 1994–1995
  Crude 1.00 
(reference)
0.45 (0.25 to 0.81) 0.44 (0.21 to 0.93) 1.00 
(reference)
0.71 (0.42 to 1.18) 1.27 (0.70 to 2.29)
  Model 1* 1.00 
(reference)
0.47 (0.26 to 0.85) 0.52 (0.24 to 1.10) 1.00 
(reference)
0.69 (0.41 to 1.17) 1.18 (0.64 to 2.19)
  Model 2* 1.00 
(reference)
0.51 (0.28 to 0.93) 0.54 (0.27 to 1.20) 1.00 
(reference)
0.65 (0.38 to 1.09) 1.26 (0.68 to 2.34)
Tromsø 5 2001–2002
  Crude 1.00 
(reference)
0.69 (0.50 to 0.97) 0.59 (0.37 to 0.94) 1.00 
(reference)
0.99 (0.76 to 1.29) 1.08 (0.75 to 1.55)
  Model 1* 1.00 
(reference)
0.80 (0.57 to 1.12) 0.79 (0.49 to 1.28) 1.00 
(reference)
0.98 (0.74 to 1.28) 1.12 (0.77 to 1.62)
  Model 2* 1.00 
(reference)
0.83 (0.59 to 1.17) 0.87 (0.54 to 1.39) 1.00 
(reference)
0.98 (0.74 to 1.29) 1.10 (0.76 to 1.59)
Tromsø 6 2007–2008
  Crude 1.00 
(reference)
0.61 (0.47 to 0.79) 0.31 (0.22 to 0.43) 1.00 
(reference)
0.82 (0.66 to 1.03) 0.63 (0.48 to 0.84)
  Model 1* 1.00 
(reference)
0.77 (0.59 to 1.01) 0.46 (0.33 to 0.64) 1.00 
(reference)
0.85 (0.67 to 1.06) 0.67 (0.50 to 0.90)
  Model 2* 1.00 
(reference)
0.85 (0.64 to 1.11) 0.54 (0.39 to 0.75) 1.00 
(reference)
0.86 (0.68 to 1.08) 0.68 (0.51 to 0.92)
Tromsø 7 2015–2016
  Crude 1.00 
(reference)
0.52 (0.40 to 0.69) 0.28 (0.21 to 0.37) 1.00 
(reference)
0.82 (0.64 to 1.05) 0.74 (0.57 to 0.95)
  Model 1* 1.00 
(reference)
0.65 (0.49 to 0.87) 0.40 (0.30 to 0.54) 1.00 
(reference)
0.81 (0.63 to 1.04) 0.74 (0.57 to 0.95)
  Model 2* 1.00 
(reference)
0.69 (0.52 to 0.91) 0.48 (0.36 to 0.65) 1.00 
(reference)
0.81 (0.63 to 1.05) 0.76 (0.59 to 0.99)
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lowest education and lowest in the group with highest 
education (figure 1 and table 2). In pooled data from 
all four surveys, after adjustment for age and sex, the 
groups with secondary and tertiary education had lower 
relative prevalence of undiagnosed diabetes (aPR 0.75, 
95% CI: 0.63 to 0.88 and 0.54, 95% CI: 0.44 to 0.66, 
respectively), compared with those with primary educa-
tion only (table 3). Higher education was inversely asso-
ciated with undiagnosed diabetes and this association was 
stronger in women than in men (table 3), with a signif-
icant interaction (p=0.04). The educational gradient in 
undiagnosed diabetes did not significantly vary by time 
(all p(interaction)>0.16).
Household income in Tromsø 6 and 7 was also inversely 
associated with prevalence of undiagnosed diabetes even 
after adjustment for education. However, there was no 
significant association between income and undiagnosed 
diabetes as a proportion of all diabetes (online supple-
mental table 2).
Healthcare consumption
Around 80% people with undiagnosed diabetes had been 
in contact with a GP in the past 12 months (figure 2), 
similar to participants without diabetes, and consistent 
among men and women, age groups, education, income 
and BMI (online supplemental table 3). After adjustment 
for sex, age, BMI and education, the OR for GP contact 
in those with undiagnosed diabetes compared with those 
without diabetes was non- significant for the four surveys 
(figure 2).
Sensitivity analysis
We reran the analyses of undiagnosed diabetes in Tromsø 
7 by adding those who reported previous but not current 
diabetes to the group with known diabetes. This resulted 
Figure 1 Age- standardized diabetes prevalence by 
educational level in Tromsø 4 (1994–1995), Tromsø 5 
(2001), Tromsø 6 (2007–2008) and Tromsø 7 (2015–2016). 
In white, percentage of known diabetes and in gray 
percentage of undiagnosed diabetes; defined as HbA1c 
measurement ≥6.5% (48 mmol/mol) and no self- reported 
diabetes. The percentage value on the top of the bars 
represents the proportion of undiagnosed diabetes to all 
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in undiagnosed diabetes as a proportion of all cases being 
lower in Tromsø 7 (20.9%, 95% CI: 18.8 to 23.1), while 
stratification by educational level showed similar propor-
tions of undiagnosed diabetes cases as in the main anal-
yses, 24.9%, 20.0% and 19.4% for primary, secondary, 
and tertiary education, respectively.
We studied the influence of repeated participation 
in previous surveys and related diabetes screening. The 
repetitive surveys may have influenced the proportion 
of undiagnosed diabetes in the study population at later 
time points (online supplemental table 4).
DISCUSSION
Using ~45 000 HbA1c measurements from repeated 
population- based surveys during 1994–2016 in Tromsø 
municipality in Norway, we found that the prevalence 
of undiagnosed diabetes was lower among those with 
higher education, and we found a similar pattern for 
undiagnosed diabetes as a proportion of all diabetes. 
Our hypothesis that people with undiagnosed diabetes 
tend to seek medical care less often was not supported 
as most participants with undiagnosed diabetes had been 
in contact with a GP to the same extent as participants 
without diabetes.
The proportion of undiagnosed cases depends on 
the diagnostic criteria used, with a higher prevalence of 
undiagnosed cases typically found when using OGTT, and 
to some extent FPG, compared with a definition based 
on HbA1c.
24 25 The Tromsø Study has been repeated at 
regular intervals and participants were provided informa-
tion about abnormal values, and we believe that this may 
have affected the proportion of undiagnosed diabetes 
and the screening in the Tromsø municipality,12 espe-
cially in the Tromsø 5 and Tromsø 6 surveys where many 
individuals had participated in previous survey.
Social inequality in health is a major public health chal-
lenge.26 Understanding determinants of such inequali-
ties is critical to improve the healthcare system and get 
optimal health treatments to all individuals. A previous 
study of older women in the UK based on FPG did not 
report any association between socioeconomic status and 
undiagnosed diabetes.27 In a study using National Health 
and Nutrition Examination Survey (NHANES) data 
(men only), higher proportion of undiagnosed cases was 
found in those with low education compared with those 
with high education, consistent with our results.18 Our 
findings that education and income were associated with 
undiagnosed diabetes were consistent with a British study 
on an annual sample from 2009 to 2013.28
It is important to clarify the extent to which people 
with undiagnosed diabetes have been in contact with 
the healthcare service, as this could identify a room for 
improvement in the system and there are few published 
studies on this topic.11 29 30 Our results indicate that 
most participants with undiagnosed diabetes had been 
in contact with a GP during the last 12 months, similar 
results were found in a Danish study where 72% of those 
with undiagnosed diabetes had been in contact with their 
GP.29 Clinical guidelines typically advise GPs to test HbA1c 
in patients with risk factors such as high BMI, high age, 
and family history of diabetes. However, many of the 
screening- identified participants in our study had in fact 
high BMI or age. In contrast to our findings, studies from 
Germany30 and the USA11 found that those with undiag-
nosed diabetes reported less frequent contact with the 
health system in the previous year.
We could speculate that opportunistic screening for 
diabetes has increased over time in Norway, based on 
the decreased proportion in undiagnosed diabetes and 
the increased availability of HbA1c point- of- care testing. 
HbA1c was not recommended as a diagnostic test in 
Norway before 2012, however GPs may have started using 
the test before that time.
Strengths and limitations
The main strength of the present study was the use of 
a large population- based sample and a high number of 
HbA1c measurements. Data collection throughout two 
decades enabled us to examine the association of educa-
tion on undiagnosed diabetes prevalence over time. We 
also provided updated estimates of undiagnosed diabetes 
across categories by sex, age groups, and BMI. Our study 
included people born over a long period of time, during 
which the average educational attainment has increased. 
Figure 2 Percentage of participants who visited a general 
practitioner during the last 12 months prior to screening 
visit among participants with undiagnosed diabetes and 
no diabetes. Tromsø 4 (1994–1995), Tromsø 5 (2001), 
Tromsø 6 (2007–2008) and Tromsø 7 (2015–2016). In white, 
percentage of participants without diabetes and in gray 
percentage of undiagnosed diabetes, defined by an HbA1c 
measurement ≥6.5% (48 mmol/mol) and not self- reported 
diabetes. After adjustment for sex, age, BMI and education, 
the OR for general practitioner contacts in those with 
undiagnosed diabetes compared with those without diabetes 
was 1.18 (p=0.64) in Tromsø 4. In Tromsø 5, the OR was 
0.84 (p=0.45), in Tromsø 6 the OR was 1.09 (p=0.67) and 
in Tromsø 7 the OR was 0.80 (p=0.17). Results stratified 
by sex, age, education, income, and BMI are shown in the 
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We controlled confounding by time trends by adjusting 
for both age and period of survey.
HbA1c test is highly specific but has poor sensitivity 
to diagnose diabetes compared with other methods, 
especially OGTT.31 Some misclassification is therefore 
expected. Furthermore, we classified cases based on 
one single test, without the recommended confirmatory 
test for clinical diagnosis in asymptomatic individuals.11 
On balance, however, HbA1c is probably the best single 
test for use in epidemiological studies.25 During the 
study period, the WHO diagnostic criteria for diabetes 
used changed twice. In 1999, the diagnostic cut- off for 
FPG was lowered from 7.8 mmol/L to 7.0 mmol/L, that 
may have led to a lower prevalence of known diabetes 
in the earliest data collection (Tromsø 4). However, 
before 1999, OGTT was commonly regarded as a gold 
standard for diagnosis and use for this test in clinical 
practice would have the opposite effect due to its higher 
sensitivity. Another limitation of our study is that HbA1c 
was measured using different methods in the four data 
collections, and HbA1c instruments were not calibrated 
across surveys.
The pooled estimate should be interpreted with 
caution due to differences in sampling procedures across 
the surveys, although we have adjusted for the main 
confounders in the regression analysis. Some age groups 
were over- represented in some surveys, however, we age 
standardized the data using the last survey (with a high 
number of participants) to enable comparison between 
surveys. The pooled results of education and diabetes 
are driven mostly by results from Tromsø 6 and 7 due to 
larger number of participants. However, while there was 
some variation in point estimates of educational gradient 
over time, this variation was not statistically significant. In 
the latest survey, the question on self- reported diabetes 
may have introduced a possibility of misclassification by 
including an option to report previous but not current 
diabetes. While diabetes is normally a chronic disease, 
participants who previously, but not currently received 
glucose- lowering medication, may have answered that 
they previously had diabetes. However, the sensitivity 
analysis did not show any difference in the association 
with education and undiagnosed diabetes when these 
participants were included.
Diabetes status was self- reported. While this may be 
regarded a weakness, several studies had reported a high 
concordance between self- reported diabetes and medical 
records.32–34 As most other screening studies, we could 
not distinguish between type 1 and type 2 diabetes, but 
type 2 diabetes is known to constitute around 90% or 
more of all diabetes in this age group. We cannot rule 
out that some women with previous gestational diabetes 
may have reported having had diabetes. In the last survey, 
most of these women are likely to have reported having 
had diabetes previously (and not currently), and we 
therefore believe that gestational diabetes erroneously 
reported as known diabetes has not seriously biased 
our result (women who were currently pregnant were 
removed from the analysis so current gestational diabetes 
cannot have influenced our results).
Population- based studies may be prone to selection 
bias, due to healthier participants being more willing 
to participate.35 However, individuals with undiagnosed 
diabetes may be ‘symptom free’ in most of the cases. 
The Tromsø Study is representative for the inhabitants 
of Tromsø municipality in the studied age groups, with 
most of the participants being Caucasian, however, ethnic 
minorities are under- represented.
In conclusion, undiagnosed diabetes was lower among 
participants with tertiary education, both in prevalence 
and as a proportion of all diabetes. There was no differ-
ence in the proportion of participants in contact with 
their GP among undiagnosed diabetes compared with 
participants without diabetes. Knowing the proportion 
of undiagnosed diabetes and the distribution in different 
socioeconomic strata may help to develop targeted strat-
egies in screening and prevention.
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